These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Efficacy of mycobacterial cell walls as a vaccine against airborne tuberculosis in the Rheusus monkey. Ribi E; Anacker RL; Barclay WR; Brehmer W; Harris SC; Leif WR; Simmons J J Infect Dis; 1971 May; 123(5):527-38. PubMed ID: 5000470 [No Abstract] [Full Text] [Related]
26. Immunotherapy of cancer: regression of established intradermal tumors after intralesional injection of mycobacterial cell walls attached to oil droplets. Zbar B; Ribi E; Meyer T; Azuma I; Rapp HJ J Natl Cancer Inst; 1974 May; 52(5):1571-7. PubMed ID: 4364736 [No Abstract] [Full Text] [Related]
27. Effect of Micrococcus, BCG and structurally related polysaccharides on the adjuvanticity to a T cell-dependent antigen [proceedings]. Verloes R; Huygen K; Bechers E; Atassi G; Kanarek L Arch Int Physiol Biochim; 1979 Oct; 87(4):860-2. PubMed ID: 93950 [No Abstract] [Full Text] [Related]
28. Hydrosoluble immunostimulants of bacterial and synthetic origins. Jollès P Experientia; 1976 Jun; 32(6):677-83. PubMed ID: 181265 [TBL] [Abstract][Full Text] [Related]
29. Cross reactivity of lepromin with other mycobacterial antigens. Goihman-Yahr M; Raffel S; Ferraresi RW Int J Lepr Other Mycobact Dis; 1968; 36(2):129-43. PubMed ID: 4877112 [No Abstract] [Full Text] [Related]
30. Mycobacterial cell wall components in tumor suppression and regression. Ribi EE; Meyer TJ; Azuma I; Zbar B Natl Cancer Inst Monogr; 1973 Dec; 39():115-9. PubMed ID: 4595311 [No Abstract] [Full Text] [Related]
31. Structure of Freund's complete and incomplete adjuvants. Relation of adjuvanticity to structure. Dvorak AM; Dvorak HF Immunology; 1974 Jul; 27(1):99-114. PubMed ID: 4605156 [TBL] [Abstract][Full Text] [Related]
32. Adjuvant activity of bacterial peptidoglycans on the production of delayed hypersensitivity and on antibody response. Nauciel C; Fleck J; Martin JP; Mock M; Nguyen-Huy H Eur J Immunol; 1974 May; 4(5):352-6. PubMed ID: 4604064 [No Abstract] [Full Text] [Related]
34. [The influence of Mycobacterium bovis BCG-prague, respectively of Mycobacterium smegmatis on the growth of the intratracheally transplanted Deal's sarcoma in guinea pigs (author's transl)]. Schwartz E; Vincúrová M; Badalik L Bratisl Lek Listy; 1975 Sep; 64(3):272-84. PubMed ID: 1098744 [No Abstract] [Full Text] [Related]
35. Rate of antigen catabolism and immunogenicity of [131-I]BGG in mice. I. Action of mycobacterial adjuvants. Stark JM Immunology; 1970 Sep; 19(3):449-56. PubMed ID: 4919426 [TBL] [Abstract][Full Text] [Related]
36. Biologically active components from mycobacterial cell walls. IV. Protection of mice against aerosol infection with virulent mycobacterium tuberculosis. Ribi E; Meyer TJ; Azuma I; Parker R; Brehmer W Cell Immunol; 1975 Mar; 16(1):1-10. PubMed ID: 803876 [No Abstract] [Full Text] [Related]
37. Adjuvant activity of mycobacterial fractions: adjuvant activity of synthetic N-acetylmuramyl-dipeptide and the related compounds. Azuma I; Sugimura K; Taniyama T; Yamawaki M; Yamamura Y Infect Immun; 1976 Jul; 14(1):18-27. PubMed ID: 820642 [TBL] [Abstract][Full Text] [Related]